Search by Drug Name or NDC

    NDC 58552-0130-04 Giltuss Cough and Cold 15; 300; 10 mg/5mL; mg/5mL; mg/5mL Details

    Giltuss Cough and Cold 15; 300; 10 mg/5mL; mg/5mL; mg/5mL

    Giltuss Cough and Cold is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Gil Pharmaceutical Corp. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 58552-0130
    Product ID 58552-130_08751c7f-e001-8f9d-e063-6394a90a30af
    Associated GPIs 43997303100930
    GCN Sequence Number 040291
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 300-15-10 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 53093
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Brand
    Proprietary Name Giltuss Cough and Cold
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 15; 300; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Gil Pharmaceutical Corp
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 58552-0130-04 (58552013004)

    NDC Package Code 58552-130-04
    Billing NDC 58552013004
    Package 1 BOTTLE in 1 CARTON (58552-130-04) / 118 mL in 1 BOTTLE
    Marketing Start Date 2018-10-02
    NDC Exclude Flag N
    Pricing Information N/A